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Dietary lipid-dependent regulation of de novo
lipogenesis and lipid partitioning by ketogenic
essential amino acids in mice
N Nishikata, N Shikata, Y Kimura and Y Noguchi
Institute for Innovation, Ajinomoto Co. Inc., Kawasaki, Japan
Background: We have previously reported that dietary ketogenic amino acids (KAAs) modulate hepatic de novo lipogenesis
(DNL) and prevent hepatic steatosis in mice. However, the dependence of the metabolic phenotypes generated by KAA on the
type of dietary lipid source remains unclear.
Objective: The aim of this study was to assess the effect of KAA combined with different dietary lipid sources on hepatic DNL
and tissue lipid partitioning in mice.
Design: We compared three different KAA-supplemented diets, in which a portion of the dietary protein was replaced by five
major essential amino acids (Leu, Ile, Val, Lys and Thr) in high-fat diets based on palm oil (PO), high-oleic safflower oil (FO) or
soy oil (SO). To compare the effects of these diets in C57B6 mice, the differential regulation of DNL and dietary lipid partitioning
due to KAA was assessed using stable isotopic flux analysis.
Results: The different dietary oils showed strikingly different patterns of lipid partitioning and accumulation in tissues. High-PO
diets increased both hepatic and adipose triglycerides (TG), whereas high-FO and high-SO diets increased hepatic and adipose
TG, respectively. Stable isotopic flux analysis revealed high rates of hepatic DNL in high-PO and high-FO diets, whereas it was
reduced in the high-SO diet. KAA supplementation in high-PO and high-FO diets reduced hepatic TG by reducing the DNL of
palmitate and the accumulation of dietary oleate. However, KAA supplementation in the high-SO diet failed to reduce hepatic
DNL and TG. Interestingly, KAA reduced SO-induced accumulation of hepatic linoleate and enhanced SO-induced accumulation
of dietary oleate.
Conclusions: Overall, the reduction of hepatic TG by KAA is dependent on dietary lipid sources and occurs through the
modulation of DNL and altered partitioning of dietary lipids. The current results provide further insight into the underlying
mechanisms of hepatic lipid reduction by amino acids.
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Introduction
The rising prevalence of obesityFa major health concern
worldwideFhas been linked to a number of cardiovascular
and metabolic disorders, such as hypertension, insulin
resistance, hyperlipidemia and, more recently, non-alcoholic
fatty liver disease, also known as hepatic steatosis.
1,2 Physical
inactivity, dietary behavior and inherited predisposition are
the predominant causes of excessive fat accumulation in
adipose and non-adipose tissues, which subsequently leads
to metabolic disorders. In diets designed to prevent and treat
such excessive fat accumulation by manipulating energy
content, macronutrient distribution has been examined by
controlling the proportions of fat, carbohydrate and protein,
commonly with reductions in dietary fat.
3,4 Although this
approach appears to be effective for reducing energy density
and increasing the loss of lipids in adipose tissue in the short
term,
3,4 increased dietary carbohydrate levels activate de novo
lipogenesis (DNL) to compensate for the lower fat intake
and then induce lipid accumulation in non-adipose tissues
in the long term.
5,6 Likewise, a low-carbohydrate diet has
been shown to be an effective approach for body fat
reduction in the short term, but the long-term effects have
not been established.
7 Recent studies in humans show that
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lipid deposition.
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In addition to macronutrient proportions, specific
macronutrient elements such as sugars,
9 fatty acids
10 and
amino acids
11,12 are important factors in the regulation
and dysregulation of lipid metabolism. For example, the
difference between monounsaturated fatty acids (MUFAs)
and saturated fatty acids (SFAs) has been well charac-
terized;
13–15 these two types of fatty acid affect postprandial
lipid metabolism differently.
16,17 In addition, polyunsatu-
rated fatty acid (PUFA) supplementation has been reported
to prevent insulin resistance
18,19 and hepatic steatosis.
20,21
Several reports suggest that dietary medium-chain fatty acids
promote energy expenditure and fatty acid oxidation and
improve lipid metabolism in rats
22 and humans
23 compared
with long-chain fatty acids.
Previous studies have shown that dietary withdrawal of
the essential amino acids lysine or threonine induces severe
hepatic steatosis in rodents.
11,12 Furthermore, a role for the
amino-acid deprivation sensor GCN2 in regulating hepatic
lipid homeostasis has recently been revealed.
24,25 Leucine
and lysine, which are both ketogenic amino acids (KAAs),
have unique metabolic characteristics and produce various
short-chain fatty acyl-CoAs, such as isovalaryl-CoA,
3-hydroxy-3-methylglutaryl-CoA and glutaryl-CoA, through
catabolism. In addition to leucine and lysine, isoleucine,
valine and threonine also produce short, branched-chain
acyl-CoAs.
26 A few studies have reported the potential
importance of these branched-chain acyl-CoAs in regulating
lipid homeostasis through transcription factors or nuclear
receptors.
27,28 We previously reported that the supplementa-
tion of KAA that generate acyl-CoA rescued palmitate-
induced hepatic lipoapoptosis in vitro
29 and also prevented
hepatic steatosis through the repression of DNL in mice.
30
However, the underlying mechanisms and effects of KAA
versus dietary lipid species on these phenotypes have yet
to be elucidated.
In this study, we examined KAA supplementation in
C57B6 mice fed either a regular high-lard diet or one of
three different high-fat diets (HFDs), that is, SFA-rich palm
oil (PO), MUFA-rich high-oleic safflower oil (FO) and PUFA-
rich soy oil (SO) diets. Using gas chromatography–mass
spectrometry (GC-MS)-based lipid profiling and stable
isotopic metabolic flux analysis, we assessed the dependence
of the effect of KAA on the type of dietary lipid in terms of
both the regulation of hepatic DNL and the dietary lipid
partitioning to tissues.
Materials and methods
Animals
All studies were reviewed and approved by the Animal Care
Committee of Ajinomoto Co. Inc. Ten-week-old male C57B6
mice and ob/ob mice, were obtained from Charles River
Laboratory, Japan Inc. (Yokohama, Japan). All mice were
housed in colony cages and maintained on a 12:12-h light
and dark rhythm with free access to water. After 3h of
fasting, blood was collected on ice in tubes containing EDTA
(NONCLOT-D, Daiichi Pure Chemicals, Tokyo, Japan). Liver,
epididimal fat and gastrocnemius muscle samples were
collected for lipid and gene expression analysis. All collected
tissues were snap-frozen in liquid nitrogen and stored at
 801C.
Diets
As documented in our previous report, we manipulated
dietary amino-acid composition by replacing part of the
protein content with a free amino-acid mixture in either a
control diet or a high-KAA diet.
30 Supplementary Tables S1
and S2 show the composition of the diets used in this study.
The casein-mimic-free amino-acid mixture used for the
control diet contained the following components: 2.5%
His, 4.5% Phe, 8.8% Lys-HCl, 1.1% Trp, 3.8% Thr, 2.4% Thr,
2.4% Met, 4.5% Ile, 5.7% Val, 8.1% Leu, 9.4% Pro, 9.4% Asn
H2O, 4.9% Tyr, 2.6% Ala, 3.3% Arg, 5.1% Ser, 9.2% Glu, 9.2%
Gln, 1.6% Gly, 0.5% cysteine, 3.2% Asp and 6.2% starch. On
the basis of the partial protein replacement by free KAA, the
essential amino acid/non-essential amino acid ratio in the
diet was fortified from the control value of 0.8 (for casein)
to 1.76. To avoid differences in the amounts of dietary total
amino acids, fat and carbohydrates among the diets, the
total amino acids, including protein–amino acids, were
equalized, if necessary, using casein-mimic-free amino-acid
mixture to provide 20% of dietary calories. On the basis of
this protocol, we prepared the high-lard diet and the three
different types of HFDs consisting of PO, FO and SO. As a
percentage of total energy, the diets consisted of 26.4%
carbohydrate, 52.6% fat and 20% protein plus amino acids.
The high-KAA diet contained 13.1% basal casein, with 6.9%
consisting of a selected KAA mixture of leucine, isoleucine,
valine, lysine and threonine in the proportions shown in
Supplementary Tables S1 and S2.
Blood biochemistry
Blood glucose, cholesterol and triglycerides (TG) were
measured using DRI-CHEM5500 (Fujifilm, Tokyo, Japan).
Plasma-free fatty acids were determined using an enzymatic
method with an automated kit according to the manufacturer’s
specifications (Wako Pure Chemical Industries, Osaka, Japan).
Serum leptin and insulin were determined using commercial
mouse ELISA kits (Seikagaku-kogyo Co., Tokyo, Japan).
Energy expenditure
The energy expenditure of individual mice was measured
using indirect calorimetry. An animal was housed in a
metabolic cage for 24h, allowing for the separate collection
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28 Food was available between 1900 and
0800hours. Oxygen consumption and CO2 production were
determined every 5min in an open chamber with the mass
spectrometry-based O2 and CO2 analyzer ARCO-2000 (ARCO
system, Chiba, Japan). Oxygen consumption was normalized
by lean body mass.
Tissue lipid extraction
Liver lipid extraction was performed using isopropanol and
hexane based on a modification of a method described
previously.
31 This procedure extracts a mixture of TG,
diglycerides, mono-glycerides, cholesterol, fatty acids and
other polar lipids. After extraction, fractionation was
performed to collect each lipid class. In brief, 150mg of
liver or 40mg of epididymal fat tissue was homogenized in
1.5ml of isopropanol and then sonicated for 30min after
the addition of 3ml hexane. As an internal standard, 0.1mg
triheptadecanoic acid was added to each sample. The
homogenate was incubated overnight for further extraction.
After the addition of 1ml saline, the mixture was centrifuged
at 3500r.p.m. for 15min, and the supernatant was collected
into new tubes.
Because the extracted solvent contains a mixture of
different classes of lipids, fractionation was performed to
efficiently analyze each class of lipids using a silica gel
column together with gradual elution with solvents
of increasing polarity as described in a previous report.
32
The extracted solvent was evaporated to dryness, resolved
in 500ml of isooctane/ethyl acetate (10:1) and applied to a
preequiberated silica gel column (InertSep SI, GL Sciences,
Tokyo, Japan). The column was then eluted with 4ml
isooctane/ethyl acetate (10:1). This fraction contained
cholesterol esters and TG. This process was repeated with
isooctane/ethyl acetate (3:1) and methanol, and each elutant
contained free fatty acids, diglycerides and polar lipids.
Lipid analysis by GC-MS
To analyze the fatty acid profile of TG, the triglyceride
fraction was saponified with 0.5N NaOH dissolved in
methanol, and methyl was esterized with boron trifluoride
as described previously.
29 The fatty acid methyl esters
were analyzed using electron impact ionization by GC-MS
on an Agilent 5975C model coupled with a 7890A model
gas chromatograph (Agilent, Santa Clara, CA, USA). A
DB-225ms capillary column (30m 0.25mm film 0.25mm,
Agilent) was used in all lipid analyses. The initial oven
temperature was 1901C, which was then increased by
31Cmin
 1 to 2301C and held for 2min. The Mass Selective
Detector (MSD) transfer line was set at 2801C. The
components of the sample were repetitively scanned from
50 to 550m/z. The MS quad was 1501C, and the MS source
was set at 2301C.
Peak enumeration and spectral deconvolution was performed
b yA M D I Ss o f t w a r e( h t t p : / / c h e m d a t a.nist.gov/mass-spc/amdis/;
National Institute of Standards and Technology). The resulting
ELU files (output from AMDIS) were further analyzed by
SpectConnect software (http://spectconnect.mit.edu/) to identify
well-conserved peaks among multiple GC-MS chromatograms.
33
Lipogenic flux estimation
Two weeks before killing, mice were given an intraperitoneal
injection of deuterated water (D2O) equal to 4% of their
body weight in saline at 1000 hours. Animals were then
maintained on drinking water containing 6% D2O for 2
weeks. This procedure was designed to maintain deuterium
enrichment in the body water at around 3–4% throughout
the study. Animals were fasted for 3h before killing.
Using D2O and mass isotopomer analysis, the rates of
synthesis can be calculated from the ratio of isotope-labeled
fatty acids to unlabeled fatty acids.
34,35 The major peaks in
the ion chromatogram of fatty acids in the liver are the long-
chain fatty acids palmitate (16:0), stearate (18:0) and oleate
(18:1). The fractional synthesis rates of these three fatty acids
were calculated. The chain elongation flux of palmitate to
stearate was determined by dividing the amount of newly
synthesized C18:0 by that of newly synthesized 16:0. The
desaturation flux of stearate to oleate was calculated by
dividing the amount of newly synthesized 18:1 by that of
newly synthesized 18:0. The deuterium enrichment of body
water was determined by isotopic exchange with [U-
13C3]
acetone as described previously.
36
Real-time PCR
Total RNA was extracted from homogenized liver using
an RNeasy kit (Qiagen, Germantown, MD, USA) following
the manufacturer’s instructions. Messenger RNA was then
extracted from total RNA preparations using an Oligotex
kit (Qiagen) following the manufacturer’s instructions. The
quality and integrity of the RNA were checked using the
A260/280 ratio and electrophoresis on a formaldehyde/agarose
gel, respectively. Equal amounts of RNA were reverse
transcribed using Superscript II reverse transcriptase (Invi-
trogen, Carlsbad, CA, USA) as per the manufacturer’s
instructions. Primers for reverse transcriptase-PCR were
designed using the primer design software Primer3, after
which the sequence homology for related proteins was
checked. Specifically, 18S ribosomal RNA primers were
used as an endogenous control. Reverse transcriptase-PCR
was performed on an ABI Prism 7700 Sequence Detection
System (PE Applied Biosystems, Foster, CA, USA), and the
data obtained were analyzed using the provided software.
The reaction mixture consisted of 4ml complementary DNA
template, 10ml Sybr Green PCR master mix (Roche Biochem-
icals, Indianapolis, IN, USA), 2ml 0.25–1mM forward primer
and 2ml 0.25–1mM reverse primer in a 20ml reaction volume.
The PCR protocol consisted of a single 10min denaturation
cycle at 951C followed by 40 cycles of denaturation at 951C
for 15s and annealing/extension at 601C for 1min. Standard
curves for each gene and endogenous 18S ribosomal RNA
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was 100%, and the R
2-value was between 0.995 and 0.999.
All reverse transcriptase-PCR data were expressed as relative
mRNA levels after normalization to 18S ribosomal RNA.
Primer pair sequences are listed in Supplementary Table S3.
Statistics
Data are presented as the means±s.e.m. unless otherwise
indicated. Data were analyzed by one-way analysis of
variance using Tukey’s post hoc test to determine statistical
significance for all pairwise multiple comparison procedures
and Dunnett’s test for multiple comparisons against the
control group.
Results
Effect of KAA on obese mice models
We first examined KAA fortification in C57B6 mice fed either
the low-fat diet (LFD) or the lard-based HFD. Before the
experiment, mice were fed either LFD or HFD for 2 months
(pre-LFD or pre-HFD). At day 0, the average body weights of
mice in the pre-LFD and -HFD groups were 31.6±0.3 and
37.1±0.5, respectively. Under pre-LFD conditions, the
4 weeks of high-KAA diets significantly reduced body weight
gain (BWG) in both LFD and HFD (Figure 1a right panel and
Figure 1b). In pre-HFD conditions, however, the high-KAA
diet reduced BWG only in LFD, but no clear reduction was
seen in HFD. Table 1 summarizes weights of the liver, kidney,
gastrocnemius and soleus muscle as well as the different part
of adipose tissues at the end of experiment. No significant
changes in these tissue weights were observed, except for
adipose. During the experimental period, KAA fortification
of the HFD had no effect on food intake, but reduced
the amount of food intake on the LFD. KAA fortification of
the HFD increased oxygen consumption without changes
in the respiratory quotient compared with the control HFD
(Figures 1d and e).
Under pre-LFD conditions, the high-KAA diets signi-
ficantly reduced postprandial insulin and fat accumulation
for both the LFD and the HFD. The pre-HFD, high-KAA diets,
however, reduced those two parameters only under the
LFD condition, but had no effect under HFD conditions
(Figure 2a). Unlike plasma insulin and fat accumulation,
the high-KAA diets reduced hepatic fat contents in all
conditions, with more significant reductions under HFD
conditions than under LFD conditions (Figure 2a, bottom).
To further understand the associations between postprandial
insulin and both hepatic and adipose fat accumulations,
we examined dietary KAA fortification in hyperinsulinemic
ob/ob mice. The ob/ob mice were fed an HFD or LFD for
2 weeks with or without dietary KAA fortification. In ob/ob
mice, the high-KAA diet reduced postprandial insulin only
in the LFD (Figure 2b). The KAA diets significantly reduced
hepatic fat conditions under both the LFD and the HFD.
Similarly, in C57B6 mice under HFD conditions, the
reduction due to the high-KAA diet was more significant in
improving hepatic steatosis than under the LFD (Figures 2b
and c). The dietary KAA fortification did not affect body fat
content in ob/ob mice after at least 2 weeks of feeding
(Figure 2b).
Effect of KAA on varying dietary lipid-induced metabolic
phenotypes
These metabolic changes under dietary KAA fortification in
both C57B6 and ob/ob mice suggest that KAA fortification
predominately affects hepatic fat rather than adipose fat
contents, and it is more effective under high-fat conditions.
To address the relationship between dietary KAA and fatty
types, we next compared three different KAA-supplemented
HFDs, namely, PO-, FO- or SO-based diets. The control LFD
was prepared by blending the three oils.
Dietary lipids of these three different oils were analyzed by
GC-MS to confirm their fatty acid compositions (Figure 3a).
More than half of the fatty acids in the PO were SFA,
of which nearly 50% were palmitate (16:0) and 5% were
stearate (18:0). The FO was mostly MUFA, of which over
80% was oleate. The SO consisted primarily of PUFA, of
which 52% was linoleate (18:2) and 6% was linolenate
(18:3).
Table 2 illustrates the postprandial variables at the end of
the 8-week experimental period. The high-KAA diet signifi-
cantly reduced postprandial plasma cholesterol in the high-
PO and high-FO conditions, whereas no clear reduction was
observed in mice consuming the high-SO diet. Although
HFD feeding caused only slight increases in blood glucose
and TG in comparison to the LFD group, the high-KAA diet
almost normalized these values in mice consuming the HFDs
(Table 2). Under these conditions, no significant changes in
food intake were observed between control, high-fat and
KAA fortified groups (Figure 3b). BWG due to high-PO or
high-SO feeding was significantly repressed by KAA fortifica-
tion, whereas no significant increase in BWG on high-FO
diets or repression by KAA feeding was observed (Figure 3c).
At the end of the 8-week experimental period, the epididy-
mal fat weight decreased by 34% in the KAA group as
compared with both the control PO and the SO groups
(Figure 4c).
Effect of KAA on hepatic lipid contents with varying dietary
lipids
As compared with the level in the control LFD group, hepatic
TG content was increased by 75 and 29% under the high-PO
and high-FO diets, respectively, whereas no significant
increase was observed under the high-SO diet (Figure 4c).
Similar trends were observed regarding hepatic cholesterol
content, which increased by 26 and 43% under the high-PO
and -FO diets. However, KAA fortification of both high-PO
and -FO diets repressed increases in both hepatic TG and
cholesterol. There were no clear changes in hepatic TG and
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control LFD group (Figure 4c).
De novo lipogenesis and lipid partitioning
To understand the mechanism of TG regulation under the
high-KAA condition, metabolic flux analysis was used to
quantify changes in DNL and non-DNL lipid partitioning to
tissues. Figure 5 summarizes the different fatty acid sources
contributing to hepatic and adipose TG in C57B6 mice fed
various diets for 8 weeks.
In fat tissue, the contribution of DNL to palmitate and
oleate contents was generally smaller and lower in all HFD
groups as compared with the control LFD group (Figure 5,
right panels). In contrast, a large contribution of DNL to
palmitate and oleate synthesis in the liver was observed
Figure 1 Effects of high-KAA diets on diet-induced obesity. Growth curves (a), body weights (b), average food intake (c), oxygen consumption (d), and respiratory
quotient (e) of C57B6 mice fed for 4 weeks with or without KAA fortification under LFD and HFD conditions (mean±s.e.m., n¼9 for each group). KAA fortifications
were started after 2 months of pretreatment of LFD or HFD (shown as pre-LFD or pre-HFD). At day 0, the average body weights of mice under pre-LFD and pre-HFD
conditions were 31.6±0.3 and 37.1±0.5, respectively. For oxygen consumption and respiratory quotients, values were obtained over 3 days following a week of
acclimatization to the metabolic chamber, and only the results from the HFD with or without KAA fortification are shown. *Po0.05 for all high-KAA groups as
compared with the control LFD or HFD groups. NS, not significant.
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LFD group; this effect was significantly reduced in mice
consuming the high-SO diet (Figure 5, left and right panels).
The different dietary oils also showed different patterns of
non-DNL partitioning and accumulation in both tissues,
presumably from different dietary fatty acids. Particularly in
the liver, high levels of PO, FO and SO increased non-DNL
palmitate, oleate and linoleate, respectively.
KAA supplementation in high-PO and high-FO diets
significantly reduced the DNL of palmitate and oleate and
the non-DNL partitioning of these two fatty acids into the
liver (Figure 5, left panels). KAA supplementation under
the high-SO condition, however, failed to reduce the hepatic
DNL and TG. Interestingly, KAA significantly reduced
SO-induced accumulation of linoleate, but increased the
non-DNL oleate in both tissues (Figure 5). In contrast, KAA
reduced FO-induced non-DNL oleate, but increased linoleate
(Figure 5).
Changes in hepatic lipogenic gene expression by dietary fat and
amino acids
Expression of hepatic genes involved in lipogenesis was
measured in response to varying HFD feeding with or
without KAA supplementation (Figure 6). The high-KAA diet
repressed the high-PO induced increase in the sterol
regulatory element-binding protein-1c (SREBP-1c), but failed
to repress expression under high-FO and high-SO diets.
Expression of adenosine triphosphate citrate lyase (ACL),
acetyl-CoA carboxylase (ACC), stearoyl-CoA reductase
(SCD-1) and Elovl-6 was reduced under all three HFDs as
compared with the control LFD group, whereas KAA
supplementation additively repressed the expression of these
enzymes, particularly in both high-PO and high-FO diets
(Figure 6). The high-SO diet dramatically decreased ACL,
ACC and SCD-1 expression by 70–90% as compared with the
LFD group; no additional effect due to KAA was observed.
Fatty acid synthase (FAS) expression was reduced in all HFDs,
Table 1 Summary of tissue weights in C57B6 mice fed varying diets
Pre-LFD Pre-HFD
LFD
(n¼9)
LFD+KAA
(n¼9)
HFD
(n¼9)
HFD+KAA
(n¼9)
LFD
(n¼9)
LFD+KAA
(n¼9)
HFD
(n¼9)
HFD+KAA
(n¼9)
Tissue weight (g)
Liver 1.42±0.05 1.34±0.03 1.56±0.05 1.35±0.04
# 1.49±0.07 1.33±0.04 1.55±0.06 1.43±0.05
Kidney 0.37±0.01 0.38±0.01 0.36±0.02 0.38±0.01 0.40±0.01 0.43±0.02 0.39±0.01 0.41±0.01
Gastrocnemius 0.168±0.002 0.171±0.005 0.168±0.003 0.176±0.004 0.178±0.003 0.172±0.004 0.176±0.005 0.177±0.006
Soleus 0.012±0.001 0.010±0.001 0.010±0.001 0.010±0.001 0.011±0.001 0.012±0.001 0.011±0.001 0.012±0.001
Epididymal fat 1.14±0.11 0.86±0.09 1.94±0.09
* 1.24±0.18
# 0.97±0.18 0.66±0.09 1.86±0.12
* 1.69±0.15
Perinephric fat 0.46±0.05 0.35±0.04 0.81±0.05
* 0.48±0.09
# 0.36±0.09 0.25±0.06 0.75±0.07
* 0.67±0.08
Subcutaneous fat 0.84±0.08 0.66±0.07 1.39±0.10
* 0.77±0.13
# 0.70±0.15 0.43±0.06 1.16±0.13
* 1.19±0.16
Abbreviations: HFD, high-fat diet; KAA, ketogenic amino acid; LFD, low-fat diet. Data represent mean±s.e.m. *Po0.05 for all high-fat groups compared with control
LFD group;
#Po0.05 for high-KAA group with control HFD.
Figure 2 Effects of high-KAA diets on adipose and hepatic fat contents.
(a) Plasma insulin (3h fast), fat mass (subcutaneous, epididymal and
perinephric) and total liver lipids in pre-LFD- and pre-HFD-treated mice fed
the indicated diet for another 4 weeks (n¼9). (b) Plasma insulin (3h fast), fat
mass and total liver lipids in ob/ob mice fed LFD and HFD with or without KAA
fortification for 2 weeks (n¼6). (c) Representative liver pictures from ob/ob
mice fed LFD, HFD and HFD with KAA fortification for 2 weeks. All values are
expressed as means±s.e.m. (n¼6). *Po0.05 for high-KAA diet compared
with the corresponding control group.
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(Figure 6). Regarding glucolytic genes, only the high-PO diet
increased the expression of glucokinase (GK) genes, and KAA
repressed such expression. In addition, no clear changes due
to KAA were observed in liver pyruvate kinase.
Correlation of lipogenic fluxes and gene expression
To understand the regulatory differences of lipogenic genes
induced by dietary lipid and amino acids, we performed
correlation analyses of lipogenic fluxes and gene expression
patterns. In this study, we estimated elongase and desaturase
fluxes in addition to palmitate synthesis (DNL of palmitate),
as shown in Figure 5, and then we compared these fluxes to
the expression of the lipogenic genes ACL, ACC, FAS, Elovl-6
and SCD-1. Figure 7 shows the correlation between palmitate
synthetic flux and related expression patterns of ACL, ACC
and FAS. The flux of palmitate synthesis shows a relatively
high correlation with ACL and ACC (r¼0.53 and 0.38,
respectively), whereas no clear correlation with FAS was seen.
Correlations between elongase flux and Evovl-6 expression
and between desaturase flux and SCD-1 expression were also
assessed; the desaturase reaction, but not the elongase
reaction, exhibited a correlation between flux and expres-
sion patterns (Figure 7).
Discussion
This study found that dietary lipids and amino acids
reciprocally affect fat accumulation in mice through the
regulation of DNL and tissue lipid distribution. Increased
intake of nutritional elements such as carbohydrates and fat
has been reported to lead to obesity and insulin resistance.
3,4
Several studies have suggested that dietary fatty acid
composition affects the development of insulin resistance,
hepatic steatosis and obesity.
10 Different types of fatty acids
display different metabolic phenotypes, including oxidation
and deposition rate differences that lead to body fat
changes.
37 The chemical structure of dietary fatty acids and
their chain length, degree of unsaturation, the position of
double bonds and their configuration seem to affect their
metabolic fate. For example, one comparison of dietary
MUFA intake with SFA revealed a decrease in fat deposition
under a diet rich in MUFA.
38 For unsaturated long-chain
fatty acids, PUFA from fish oil has been reported to decrease
fat mass in rodents.
39
To address these issues, we examined the effects of three
different diets high in PO, FO and SO on lipid metabolism in
C57B6 mice, where PO, FO and SO predominantly contained
Figure 3 Body weight gain of C57B6 mice fed different high-fat diets.
(a) Fatty acid contents in each diet were estimated based on nutritional
composition (Supplementary Table S2) and fatty acid composition in palm
oil (PO), safflower oil (FO) and soy oil (SO). Fatty acids were determined using
GC-MS as described in Materials and methods section. (b, c) Food intake and
body weight gain of C57B6 mice fed for 8 weeks with control low-fat diet
(LFD), high-palm oil (high-PO), high-safflower oil (high-FO) or high-soy oil
(high-SO) diets with or without KAA fortification was compared. In each
panel, the white square, black circle and gray circle represent low-fat diet,
control high-fat and KAA fortified high-fat diets, respectively. Average body
weight at day 0 was 27.2±0.25. All values are expressed as means±s.e.m.
(n¼6 for each group).
Table 2 Summary of metabolic parameters in C57B6 mice fed varying high-fat diet with or without KAA supplementation
High-PO High-FO High-SO
LFD (n¼6) Cont. (n¼6) KAA (n¼6) Cont. (n¼6) KAA (n¼6) Cont. (n¼6) KAA (n¼6)
Glucose (mgdl
 1) 189.5±5.3 196.7±4.8 169.8±9.8
# 209.0±7.1 187.3±12.7 220.7±3.1
* 211.3±9.2
Triglyceride (mgdl
 1) 182.5±5.7 198.3±4.8 182.7±6.6 185.4±9.7 181.0±8.1 198.1±5 175.9±8.3#
Cholesterol (mgdl
 1) 186.0±4.8 197.5±3.7 177.5±7.2# 197.2±7.6 184.2± 8.4 209.4±2.7* 193.6±8.7
Abbreviations: FO, safflower oil; HFD, high-fat diet; KAA, ketogenic amino acid; LFD, low-fat diet; PO, palm oil; SO, soy oil. Data represent mean±s.e.m. *Po0.05 for
all high-fat groups compared with LFD group;
#Po0.05 for high-KAA group with control HFD.
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differences in fat accumulation among these dietary groups;
both PO and SO (but not FO) increased BWG in mice. In
addition, PO induced fat accumulation in both liver and
adipose tissue, whereas FO and SO only induce it in liver and
adipose tissue, respectively. These differences in fat accumu-
lation in tissues can also be explained according to the
different types of dietary fat and their behaviors in lipid
metabolism. For instance, in vivo and in vitro studies have
shown that PUFA, but not MUFA nor SFA, seems to suppress
the expression of lipogenic genes primarily through de-
creased expression of SREBP-1c.
40 Our data show that all
three oils increase SREBP-1c expression in mice, but strongly
repress downstream genes such as SCD-1 and Elovl-6. The
differences in the expression of SREBP-1c and other lipogenic
genes based on different HFDs were not clear in this study.
Both the proportions of dietary fatty acid types and the
duration of treatment may further complicate the effects on
lipid metabolism.
Recent studies have shown that dietary protein could
affect fat accumulation by satiating and metabolic effects.
41
In addition, amino acid, fat and glucose metabolisms are
highly coordinated through multiple organ systems, includ-
ing the liver.
25,42,43 However, the mechanism by which
dietary amino acids regulate lipid metabolism is still unclear.
We previously reported that the manipulation of the
essential amino acid/non-essential amino acid ratio by
supplementation with both the KAA lysine and threonine
and the branched-chain amino acids prevented hepatic
steatosis through repression of DNL in mice.
30 To extend
this finding, we examined the effect of KAA supplementa-
tion on the murine lipid synthetic pathway as well as on the
fat deposition that occurs when mice are fed different HFDs.
In this study, we replicated our previous findings on the
reduction of hepatic lipid by dietary KAA in C57B6 mice, as
we investigated KAA fortification under LFD and HFD in
mice. Our data clearly duplicated a reduction in hepatic and
body fat due to KAA, with increased oxygen consumption
under HFD conditions. However, we found that KAA
supplementation had relatively less of an effect under LFD
conditions, although it introduced a slight anorexic effect
under LFD. Therefore, we hypothesized that the reduction of
Figure 4 Fat, hepatic triglyceride and cholesterol contents in C57B6 mice
fed different diets. Epididymal fat in C57B6 mice fed for 8 weeks with high-
palm oil (high-PO), high-safflower oil (high-FO) or high-soy oil (high-SO) diets
with or without KAA fortification was determined at the end of the study
(upper panel). Liver samples were obtained from C57B6 mice fed for 8 weeks
with the LFD or the varying HFD with or without KAA fortification. Hepatic TG
and cholesterol were enzymatically determined as described in the Materials
and methods section (middle and bottom panels). All values are expressed as
means±s.e.m. (n¼6 for each group). *Po0.05 for all HFD control groups as
compared with the LFD group or as indicated.
Figure 5 Fatty sources for hepatic and adipose trigylyceride in C57B6 mice
fed different diets. Metabolic flux of DNL was analyzed by identifying fatty
sources for hepatic (left panels) and adipose (right panels) triglycerides using
deuterated water labeling and mass isotopomer distribution analysis (see
Materials and methods section). The contribution of DNL to total triglyceride
fatty acids in both tissues was separately estimated for palmitate (c16:0) and
oleate (c18:1); only non-DNL values are shown for linoleate (18:2). Black and
blue bars represent DNL and non-DNL sources, respectively. All values are
expressed as means±s.e.m. (n¼6 for each group). *Po0.05 for all HFD
control groups as compared with the LFD group or as indicated.
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on dietary fat content or fatty types. Our data interestingly
showed that KAA supplementation exhibited a clear depen-
dency on dietary fatty acid types in terms of the repression of
fat deposition; KAA only decreased hepatic TG and choles-
terol content in high-PO and high-FO diets. This difference
was also observed for lipogenic gene expression. KAA
supplementation of the high-PO diet decreased the expres-
sion of SREBP-1c and SCD-1, and KAA supplementation of
the high-FO diet decreased the expression of SCD-1 and
Elovl-6. However, KAA supplementation of the high-SO diet
did not alter the expression of lipogenic genes, suggesting
that these amino acids utilize some of the same factors as
PUFA to regulate lipid metabolism. As compared with the
high-FO diet, the high-PO diet dramatically increased
hepatic GK expression, and this increase was normalized by
KAA supplementation. Differences in glycolytic regulation
by fatty acids have been reported in vitro, where palmitate,
but not oleate, directly represses GK activity or flux in liver
cells.
29,44 In addition, SERBP-1c has been reported to
modulate insulin-dependent GK regulation, indicating the
parallel regulation of glycolysis and lipogenesis.
45 The
current data do not address the mechanism by which GK is
regulated by dietary lipid or amino acids; thus, further study
of the combined effect of fatty acids and amino acids on the
regulation of hepatic glycolysis is needed.
DNL is normally assessed by profiling the expression of
lipogenic genes. However, such analyses do not cover all
possible regulatory mechanisms of the pathway because
regulation could also occur independently of gene expres-
sion. For example, regulation can also occur through
changes in substrate availability, in the phosphorylation
state of the enzymes or in allosteric regulation.
46 Therefore,
metabolic flux analysis should be used to describe the
activity or inactivity of the DNL pathway. In this study, we
examined both metabolic flux analysis and gene expression.
Although lipogenic gene expression was altered by dietary
conditions, correlation analysis extracted a limited relation-
ship between gene expression and actual fluxes. For instance,
a positive relationship was observed between desaturase flux
and SCD-1 expression. In contrast, no clear correlation was
observed between elongase flux and Elovl-6 expression,
although significant changes in gene expression were
observed. Furthermore, the DNL flux of palmitate showed a
clear correlation with ACL and ACC expression, but not with
FAS expression. Kotronen et al.
47 reported that SCD-1, but
not elongase activity, was positively correlated with hepatic
fat in non-alcoholic fatty liver diseased patients. The current
data strongly indicate that DNL can be regulated by changes
in gene expression as well as by changes in flux due to
substrate availability due to dietary components, where
amino acids may alter the upper pathway of lipogenesis
and the desaturase fluxes.
Another important finding in this study is that tissue lipid
distribution seems to be modulated by KAA supplementa-
tion, particularly in high-FO and high-SO diets. Our data
show that KAA significantly reduced SO-induced hepatic and
adipose accumulation of linoleate (18:2), although increased
oleate (18:1) was observed in both tissues. However, KAA
reduced FO-induced oleate accumulation in both tissues, but
increased linoleate accumulation in adipose tissue. The
mechanism underlying this exchange of tissue fatty acids
Figure 6 Changes in expression profiles of hepatic lipogenic genes under
different dietary conditions. Liver samples were obtained from C57B6 mice
(n¼69 for each group) fed for 8 weeks with an LFD or a varying type of HFD.
Relative gene expression levels (normalized with 18S ribosomal RNA) for
SREBP-1c, fatty acid synthase (FAS), Elovl-6, stearoyl-CoA desaturase 1 (SCD1),
adenosine triphosphate citrate lyase (ACL), acetyl-CoA carboxylase (ACC)a n d
liver under different dietary conditions were determined using reverse
transcriptase (RT)-PCR. All values are expressed as means±s.e.m. (n¼6f o r
each group). *Po0.05 for all HFD control groups as compared with the LFD
group or as indicated.
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proteins and acyl-CoA binding protein might be involved in
these phenomena because these proteins determine whether
lipid metabolites are used as an energy source or as signaling
molecules within cells. They also regulate the circulation of
lipid metabolites, which affects the tissue distribution of
lipids.
48 The KAA used in this study are known to generate
short or branched chain acyl-CoAs that might disturb
interactions with long-chain fatty acids. In addition, several
studies have examined the decreased expression of intestinal
fatty acid-binding protein and fatty acid transport protein-4
induced by branched-chain amino acids in human intestinal
cells.
49 Of course, there may be additional factors that sense
the proportion of fatty acids and amino acids in diets that
regulate hepatic lipid metabolism. Thus, further metabolic
profiling of amino-acid metabolism may be a possible
approach to relate such metabolites to the metabolic fate
of lipids and to the regulation of de novo lipid synthesis.
We studied KAA fortification in C57B6 mice after
2 months of LFD or HFD feeding. We found that KAA
fortification mitigated the reduction in body fat in the pre-
HFD-treated mice. Because we previously found that dietary
KAA prevented high-fat-induced peripheral insulin resis-
tance through the reduction of lipotoxic lipid accumula-
tions,
30 the irreversible development of peripheral insulin
resistance and the subsequent impairment in substrate
oxidation by long-term HFD feeding may explain it. In
contrast to adipose fat, KAA fortification was effective in
the reduction of hepatic fat in pre-HFD mice as well as in
hyperinsulinemic ob/ob mice. Thus, the regulation of hepatic
lipid accumulation by KAA was independent of diet-induced
insulin resistance.
In rodents, the anorexic effects of KAA loading must be
considered. The accompanied decrease in caloric intake
distorts metabolism as a whole, making the interpretation
of experimental results difficult. Leucine, methionine and
histidine have been characterized as having a strong,
negative influence on food intake in rodents.
50 Among
these, leucine was reported to stimulate mammalian target
of rapamycin signaling directly in the hypothalamus,
leading to decreased food intake.
51,52 In addition, amino-
acid imbalance caused by supplementing either a single
amino acid or a few specific amino acids negatively impacts
the so-called ‘metabolic value’ of the diet in question. Taken
together, these factors have largely confounded previous
attempts to assess the direct or upstream metabolic effects of
KAA. In this study, we did not observe a reduction in food
intake associated with feeding a mixture of selected KAA to
mice under HFD conditions, suggesting that the utilization
of multiple KAA, together with dietary fat, could alleviate the
potential for anorexic effects. This mixture was composed of
free BCAA plus lysine and threonine, which quantitatively
are the major KAA in most animal proteins. Although further
optimization of our formulation is required to elucidate the
contribution of each individual amino acid, the KAA diet
developed in this study exhibits a marked capacity to
modulate high-fat-induced metabolic alterations and to
prevent subsequent pathogenesis.
In conclusion, KAA may regulate DNL through a regula-
tory mechanism similar to that used for PUFA, but regulation
Figure 7 Correlation analysis of lipogenic fluxes and related gene expressions. DNL fluxes and gene expression were correlated. Estimations of chain elongation
from palmitate (16:0) to stearate (18:0) and desaturation to oleate (18:1) were performed as described in Materials and methods section. Obtained elongase and
desaturase fluxes were correlated to Elovl-6 and SCD-1 expression, respectively (upper panels). Also, ACL, ACC and FAS expressions were correlated to DNL-palmitate
flux (bottom panels). Data from Figures 5 and 7 (total n¼42) were used to calculate the correlation coefficients (r).
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of regulation by fatty acids. In addition, the modulation of
lipid partitioning could be another factor explaining the
lipid-reducing effect of KAA.
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